Medtronic's first-quarter results warning sends shares sliding
This article was originally published in Clinica
Executive Summary
The slowdown in the US implantable cardioverter defibrillator (ICD) market has taken its toll on Medtronic, as the world's largest medical device manufacturer warned investors that its first-quarter revenues for fiscal 2007 will not be meeting analysts' expectations.